Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Jakobsen next in line as Mead Johnson CEO; Blake takes over Bayer U.S. from Babe; Himmel ends brief tenure as ChromaDex CEO; Capitol Hill veteran O’Donnell joins NACDS; Merz makes Hartman derma VP; USANA strengthens scientist roster; more People In Brief.

You may also be interested in...



In Brief

Sunset Natural Products falls on labeling, GMPs; FDA raps Coral Rock Man for new drugs; Hillestad GMP response puzzles FDA; Natural Medicine products cross the line; ensure quality of botanical ingredients, AHPA’s Dentali says; Emerson distributes Heel homeopathics; Jakobsen takes reins at Mead Johnson.

Mead Johnson Eyes China’s One-Child Policy, Hong Kong Formula Rule

The one-child policy in much of China stifles Mead Johnson’s annual formula volume growth there, says incoming CEO Kasper Jakobsen. Formula sales there could be slowed with Hong Kong limiting the amount that consumers can take out of the territory.

Mead Johnson Eyes China’s One-Child Policy, Hong Kong Formula Rule

The one-child policy in much of China stifles Mead Johnson’s annual formula volume growth there, says incoming CEO Kasper Jakobsen. Formula sales there could be slowed with Hong Kong limiting the amount that consumers can take out of the territory.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105808

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel